Childress Capital Advisors, LLC Pfizer Inc Transaction History

Childress Capital Advisors, LLC

$511 Million
Q3 2025

A detailed history of Childress Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 26,907 shares of PFE stock, worth $663,257. This represents 0.13% of its overall portfolio holdings.

Number of Shares

26,907

Previous 16,613 61.96%

Holding current value

$663,257

Previous $402,000 70.4%

% of portfolio

0.13%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$23.29 - $25.88 $239,747 - $266,408	10,294 Added 61.96%	26,907 $685,000
Q2 2025 Jul 18, 2025	SELL	$21.59 - $24.84 $53,089 - $61,081	-2,459 Reduced 12.89%	16,613 $402,000
Q1 2025 Apr 22, 2025	BUY	$25.01 - $27.13 $134,503 - $145,905	5,378 Added 39.27%	19,072 $483,000
Q4 2024 Jan 24, 2025	SELL	$24.8 - $30.19 $775,173 - $943,648	-31,257 Reduced 69.54%	13,694 $363,000
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $27,201 - $30,824	-982 Reduced 2.14%	44,951 $1.3 Million
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $732,969 - $858,903	29,017 Added 171.54%	45,933 $1.29 Million
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $85,903 - $98,644	-3,318 Reduced 16.4%	16,916 $469,000
Q4 2023 Feb 16, 2024	BUY	$26.13 - $33.94 $11,392 - $14,797	436 Added 2.2%	20,234 $582,000
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $458,437 - $535,867	14,286 Added 259.18%	19,798 $656,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $35,614 - $41,204	-986 Reduced 15.17%	5,512 $202,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $556,895 - $724,996	-14,138 Reduced 68.51%	6,498 $265,000
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $86,547 - $112,978	2,073 Added 11.17%	20,636 $1.06 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $29,275 - $35,737	-669 Reduced 3.48%	18,563 $825,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $82,265 - $97,540	1,768 Added 10.12%	19,232 $1.01 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $116,296 - $144,105	2,542 Added 17.04%	17,464 $903,000
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $98,920 - $146,632	-2,394 Reduced 13.83%	14,922 $881,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $157,745 - $202,637	4,019 Added 30.22%	17,316 $744,000
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $1,472 - $1,667	41 Added 0.31%	13,297 $520,000
Q1 2021 May 21, 2021	BUY	$33.49 - $37.77 $191,529 - $216,006	5,719 Added 75.88%	13,256 $480,000
Q4 2020 Mar 09, 2021	BUY	$33.47 - $42.56 $252,263 - $320,774	7,537 New	7,537 $277,000

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Childress Capital Advisors, LLC with notifications on news.

Account

Childress Capital Advisors, LLC Pfizer Inc Transaction History